Cargando…
CD44-targeted hyaluronic acid–curcumin reverses chemotherapeutics resistance by inhibiting P-gp and anti-apoptotic pathways
Chemotherapeutic drug resistance poses a great challenge in cancer therapy. Drug efflux and anti-apoptotic processes are the two most common mechanisms leading to chemotherapy resistance. In this study, we focused on the applicability of curcumin (CUR) as a sensitizer for chemotherapeutics (doxorubi...
Autores principales: | Diao, Lu, Shen, Ao, Yang, Yunxu, Tao, Jin, Hu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076387/ https://www.ncbi.nlm.nih.gov/pubmed/35540044 http://dx.doi.org/10.1039/c9ra08202f |
Ejemplares similares
-
Hyaluronate Fragments Reverse Skin Atrophy by a CD44-Dependent Mechanism
por: Kaya, Gürkan, et al.
Publicado: (2006) -
Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function
Publicado: (1994) -
An energy-blocking nanoparticle decorated with anti-VEGF antibody to reverse chemotherapeutic drug resistance
por: Gu, Liu-Qing, et al.
Publicado: (2019) -
Silk peptide-hyaluronic acid based nanogels for the enhancement of the topical administration of curcumin
por: Niu, Jiangxiu, et al.
Publicado: (2022) -
Hyaluronic Acid-Based Nanosystems for CD44 Mediated Anti-Inflammatory and Antinociceptive Activity
por: Salathia, Saniya, et al.
Publicado: (2023)